← Back to Search

Digital Storytelling for Type 2 Diabetes (S4C Trial)

N/A
Waitlist Available
Led By Jane Njeru, MB, ChB
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
T2D diagnosis for six months or longer
Diagnosis of T2D in medical record
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

S4C Trial Summary

This trial will test the effectiveness of a digital storytelling intervention in promoting self-management of type 2 diabetes among Somali adults. The intervention is based on community-based participatory research and narrative theory, and was created through a partnership between Somali communities and academic institutions.

Who is the study for?
This trial is for Somali adults aged 18-70 with type 2 diabetes, who have had the condition for at least six months and a recent hemoglobin A1c level of ≥8%. Participants must receive care at Mayo Clinic ECH, have visited in the last year, and plan to continue there for six more months. Those with a household member already in the study can't join.Check my eligibility
What is being tested?
The trial tests a digital storytelling intervention aimed at improving diabetes self-management among Somali adults. It uses videos created by community members sharing their experiences managing diabetes to inspire positive behavior changes in viewers.See study design
What are the potential side effects?
Since this is not a drug or medical procedure but an educational video intervention, traditional physical side effects are not expected. However, participants may experience emotional reactions or discomfort from reflecting on personal health behaviors.

S4C Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with type 2 diabetes for at least 6 months.
Select...
My medical records show a diagnosis of type 2 diabetes.
Select...
I am between 18 and 70 years old.
Select...
I have seen my primary care doctor in the last year.

S4C Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glycemic control as measured by hemoglobin A1c. Hemoglobin A1c will be measured from whole blood samples obtained and analyzed in a blinded fashion.
Secondary outcome measures
Body mass index
Diabetes self-management behaviors will be assessed with the Summary of Diabetes Self-Care Activities Measure (SDSCA).
Seated blood pressure measurements (systolic and diastolic) will be made on the right arm using an automated blood pressure device after sitting quietly for five minutes.
+2 more

S4C Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The intervention group will view the 12-minute digital storytelling intervention that has been previously pilot-tested, in addition to usual clinical care
Group II: ControlActive Control1 Intervention
The comparison group will receive usual clinical care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Digital Storytelling Intervention
2019
N/A
~500

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,179 Previous Clinical Trials
3,758,371 Total Patients Enrolled
Jane Njeru, MB, ChBPrincipal InvestigatorMayo Clinic

Media Library

Digital Storytelling Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04266054 — N/A
Type 2 Diabetes Research Study Groups: Control, Intervention
Type 2 Diabetes Clinical Trial 2023: Digital Storytelling Intervention Highlights & Side Effects. Trial Name: NCT04266054 — N/A
Digital Storytelling Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04266054 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research accommodating participants over the age of seventy-five?

"This trial calls for participants aged 18-70. For younger and older individuals, there are 185 trials catered to those under 18 and 897 specifically designed for seniors over 65."

Answered by AI

What are the eligibility criteria needed to participate in this trial?

"To be eligible for this investigation, applicants should suffer from diabetes mellitus and range in age from 18 to 70 years old. Ultimately, the researchers seek 80 participants in total."

Answered by AI

Are there opportunities for patients to still enroll in this trial?

"Evidenced by the clinicaltrials.gov registry, this study is no longer enrolling patients; it was originally posted on 3 December 2019 and last updated 8 August 2022. Despite being closed for enrolment, there are still 1197 other studies recruiting participants presently."

Answered by AI
~15 spots leftby Mar 2025